Surgery Partners Free Cash Flow 2013-2024 | SGRY
Surgery Partners free cash flow from 2013 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Surgery Partners Annual Free Cash Flow | |
|---|---|
| 2024 | 212.30 |
| 2023 | 230.80 |
| 2022 | 91.10 |
| 2021 | 35.50 |
| 2020 | 262.50 |
| 2019 | 73.50 |
| 2018 | 124.00 |
| 2017 | 91.30 |
| 2016 | 86.13 |
| 2015 | 51.04 |
| 2014 | 14.21 |
| 2013 | 44.93 |
| 2012 | 41.68 |
| Surgery Partners Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | 212.30 |
| 2024-09-30 | 122.10 |
| 2024-06-30 | 77.10 |
| 2024-03-31 | 21.20 |
| 2023-12-31 | 230.80 |
| 2023-09-30 | 188.00 |
| 2023-06-30 | 102.60 |
| 2023-03-31 | 58.20 |
| 2022-12-31 | 91.10 |
| 2022-09-30 | 93.70 |
| 2022-06-30 | 81.30 |
| 2022-03-31 | 61.60 |
| 2021-12-31 | 35.50 |
| 2021-09-30 | 26.40 |
| 2021-06-30 | 27.00 |
| 2021-03-31 | 38.00 |
| 2020-12-31 | 262.50 |
| 2020-09-30 | 258.50 |
| 2020-06-30 | 200.60 |
| 2020-03-31 | 26.80 |
| 2019-12-31 | 73.50 |
| 2019-09-30 | 71.50 |
| 2019-06-30 | 33.00 |
| 2019-03-31 | 9.90 |
| 2018-12-31 | 124.00 |
| 2018-09-30 | 90.50 |
| 2018-06-30 | 63.90 |
| 2018-03-31 | 20.00 |
| 2017-12-31 | 91.30 |
| 2017-09-30 | 45.88 |
| 2017-06-30 | 41.37 |
| 2017-03-31 | 28.52 |
| 2016-12-31 | 86.13 |
| 2016-09-30 | 64.49 |
| 2016-06-30 | 53.69 |
| 2016-03-31 | 13.44 |
| 2015-12-31 | 51.04 |
| 2015-09-30 | 42.18 |
| 2015-06-30 | 19.44 |
| 2015-03-31 | 4.05 |
| 2014-12-31 | |
| 2014-09-30 | 25.80 |
| 2013-12-31 | |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.907B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.427B | 26.15 |
| Elevance Health (ELV) | United States | $93.171B | 12.02 |
| CVS Health (CVS) | United States | $85.832B | 10.67 |
| Cencora (COR) | United States | $55.028B | 19.14 |
| Natera (NTRA) | United States | $21.977B | 0.00 |
| DiDi Global (DIDIY) | China | $20.426B | 31.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.484B | 0.00 |
| Solventum (SOLV) | United States | $11.527B | 12.20 |
| CochLear (CHEOY) | Australia | $11.409B | 0.00 |
| ICON (ICLR) | Ireland | $11.183B | 10.40 |
| Doximity (DOCS) | United States | $11.080B | 57.62 |
| Revvity (RVTY) | United States | $10.950B | 18.84 |
| Viatris (VTRS) | United States | $10.779B | 3.67 |
| Medpace Holdings (MEDP) | United States | $8.646B | 22.96 |
| Avantor (AVTR) | United States | $8.368B | 12.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.900B | 38.86 |
| Charles River Laboratories (CRL) | United States | $6.943B | 13.60 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.924B | 36.32 |
| Sotera Health (SHC) | United States | $3.755B | 21.34 |
| Alignment Healthcare (ALHC) | United States | $3.051B | 0.00 |
| Concentras Parent (CON) | United States | $2.706B | 15.64 |
| Organon (OGN) | United States | $2.345B | 2.49 |
| Premier (PINC) | United States | $2.127B | 14.56 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 8.88 |
| Progyny (PGNY) | United States | $2.002B | 44.09 |
| GoodRx Holdings (GDRX) | United States | $1.627B | 30.29 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.582B | 61.93 |
| Agilon Health (AGL) | United States | $1.333B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.240B | 9.44 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.004B | 0.00 | |
| CareDx (CDNA) | United States | $0.857B | 13.38 |
| AMN Healthcare Services Inc (AMN) | United States | $0.776B | 7.29 |
| Embecta (EMBC) | United States | $0.773B | 5.30 |
| QDM (QDMI) | Hong Kong, SAR China | $0.674B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Enhabit (EHAB) | United States | $0.491B | 40.38 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| LifeMD (LFMD) | United States | $0.371B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.336B | 0.00 |
| DocGo (DCGO) | United States | $0.238B | 38.83 |
| Oncology Institute (TOI) | United States | $0.221B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.176B | 0.00 |
| Beauty Health (SKIN) | United States | $0.155B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |